# Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis

> **NCT03675854** · PHASE4 · WITHDRAWN · sponsor: **Chinese University of Hong Kong**

## Conditions studied

- Peritoneal Dialysis-associated Peritonitis

## Interventions

- **DRUG:** Cefazolin

## Key facts

- **NCT ID:** NCT03675854
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-01
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** New data from another study show that a positive result is unlikely.
- **Last updated:** 2019-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675854, "Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03675854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*